Identifying an obinutuzumab resistant subpopulation of monocyte-derived-macrophages from patients with CLL.

2020 
Antibody therapies are important treatment options for Chronic lymphocytic leukemia (CLL). Monocyte-derived-macrophages (MDMs) are thought to be a major immune effector that clears leukaemic cells ...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    16
    References
    1
    Citations
    NaN
    KQI
    []